Intelligent Bio Solutions Inc.
INBS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001725430
No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Intelligent Bio Solutions Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 7 | 9 | +2 |
| Shares | 5.66K | 208.4K | +202.7K (+3,581.8%) |
| Value | $53.0K | $696.9K | +$643.9K (+1,214.5%) |
New holders (6)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 130,000 | $434.9K | 0.01% |
| Alyeska Investment Group, L.P. | 37,956 | $127.0K | 0.00% |
| Geode Capital Management, LLC | 28,609 | $95.7K | 0.00% |
| Vanguard Capital Management LLC | 5,810 | $19.4K | 0.00% |
| Vanguard Fiduciary Trust Co | 3,958 | $13.2K | 0.00% |
| Advisor Group Holdings, Inc. | 200 | $670 | 0.00% |
Sold out (4)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Citigroup Inc | 76 | $724 |
| National Bank of Canada | 35 | $332 |
| SHP Wealth Management | 25 | $238 |
| Bank of America Corp | 9 | $86 |